Prostate Biopsy for the Interventional Radiologist

被引:11
作者
Hong, Cheng William [1 ]
Amalou, Hayet [1 ]
Xu, Sheng [1 ]
Turkbey, Bans [2 ]
Yan, Pingkun [1 ,4 ]
Kruecker, Jochen [1 ,4 ]
Pinto, Peter A. [3 ]
Choyke, Peter L. [2 ]
Wood, Bradford J. [1 ]
机构
[1] NCI, Ctr Intervent Oncol, Ctr Clin, NIH, Bethesda, MD 20892 USA
[2] NCI, Mol Imaging Program, NIH, Bethesda, MD 20892 USA
[3] NCI, Urol Oncol Branch, NIH, Bethesda, MD 20892 USA
[4] Philips Res North Amer, Briarcliff Manor, NY USA
基金
美国国家卫生研究院;
关键词
TRANSRECTAL ULTRASOUND PROBE; IMPROVE CANCER-DETECTION; SYSTEMATIC BIOPSY; FUSION BIOPSY; TARGETED BIOPSY; NEEDLE BIOPSIES; ANTIGEN LEVELS; GUIDED BIOPSY; COLOR; IMPACT;
D O I
10.1016/j.jvir.2013.12.568
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Prostate biopsies are usually performed by urologists in the office setting using transrectal ultrasound (US) guidance. The current standard of care involves obtaining 10-14 Cores from different anatomic sections. Biopsies are usually not directed into a specific lesion because most prostate cancers are not visible on transrectal US. Color Doppler, US contrast agents, elastography, magnetic resonance (MR) imaging, and MR imaging/US fusion are proposed as imaging methods to guide prostate biopsies. Prostate MR imaging and fusion biopsy create opportunities for diagnostic and interventional radiologists to play an increasingly important role in the screening, evaluation, diagnosis, targeted biopsy, surveillance, and focal therapy of patients with prostate cancer.
引用
收藏
页码:675 / 684
页数:10
相关论文
共 58 条
[1]   Mortality Results from a Randomized Prostate-Cancer Screening Trial [J].
Andriole, Gerald L. ;
Grubb, Robert L., III ;
Buys, Saundra S. ;
Chia, David ;
Church, Timothy R. ;
Fouad, Mona N. ;
Gelmann, Edward P. ;
Kvale, Paul A. ;
Reding, Douglas J. ;
Weissfeld, Joel L. ;
Yokochi, Lance A. ;
Crawford, E. David ;
O'Brien, Barbara ;
Clapp, Jonathan D. ;
Rathmell, Joshua M. ;
Riley, Thomas L. ;
Hayes, Richard B. ;
Kramer, Barnett S. ;
Izmirlian, Grant ;
Miller, Anthony B. ;
Pinsky, Paul F. ;
Prorok, Philip C. ;
Gohagan, John K. ;
Berg, Christine D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (13) :1310-1319
[2]  
[Anonymous], NCCN CLIN PRACT GUID
[3]   Complication rate of transrectal ultrasound guided prostate biopsy: A comparison among 3 protocols with 6, 10 and 15 cores [J].
Berger, AP ;
Gozzi, C ;
Steiner, H ;
Frauscher, F ;
Varkarakis, J ;
Rogatsch, H ;
Bartsch, G ;
Horninger, W .
JOURNAL OF UROLOGY, 2004, 171 (04) :1478-1480
[4]   MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: Initial results [J].
Beyersdorff, D ;
Winkel, A ;
Hamm, B ;
Lenk, S ;
Loening, SA ;
Taupitz, M .
RADIOLOGY, 2005, 234 (02) :576-581
[5]   LONGITUDINAL EVALUATION OF PROSTATE-SPECIFIC ANTIGEN LEVELS IN MEN WITH AND WITHOUT PROSTATE DISEASE [J].
CARTER, HB ;
PEARSON, JD ;
METTER, J ;
BRANT, LJ ;
CHAN, DW ;
ANDRES, R ;
FOZARD, JL ;
WALSH, PC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (16) :2215-2220
[6]  
Ching CB, 2009, J UROLOGY, V181, P2082
[7]   Does Transrectal Ultrasound Probe Configuration Really Matter? End Fire Versus Side Fire Probe Prostate Cancer Detection Rates [J].
Ching, Christina B. ;
Moussa, Ayman S. ;
Li, Jianbo ;
Lane, Brian R. ;
Zippe, Craig ;
Jones, J. Stephen .
JOURNAL OF UROLOGY, 2009, 181 (05) :2077-2082
[8]   SCREENING FOR PROSTATE CANCER: SHAPING THE DEBATE ON BENEFITS AND HARMS [J].
Dahm, Philipp ;
Neuberger, Molly ;
Ilic, Dragan .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (09)
[9]   Can Magnetic Resonance-Ultrasound Fusion Biopsy Improve Cancer Detection in Enlarged Prostates? [J].
Diaz, Annerleim Walton ;
Hoang, Anthony N. ;
Turkbey, Baris ;
Hong, Cheng William ;
Hong Truong ;
Sterling, Todd ;
Rais-Bahrami, Soroush ;
Siddiqui, M. Minhaj ;
Stamatakis, Lambros ;
Vourganti, Srinivas ;
Nix, Jeffrey ;
Logan, Jennifer ;
Harris, Colette ;
Weintraub, Michael ;
Chua, Celene ;
Merino, Maria J. ;
Choyke, Peter ;
Wood, Bradford J. ;
Pinto, Peter A. .
JOURNAL OF UROLOGY, 2013, 190 (06) :2020-2025
[10]   Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: When should we stop? [J].
Djavan, B ;
Ravery, V ;
Zlotta, A ;
Dobronski, P ;
Dobrovits, M ;
Fakhari, M ;
Seitz, C ;
Susani, M ;
Borkowski, A ;
Boccon-Gibod, L ;
Schulman, CC ;
Marberger, M .
JOURNAL OF UROLOGY, 2001, 166 (05) :1679-1683